Tesamorelin + Ipamorelin Blend

$85.00

Availability

Out of Stock

COA Status

Pending

Research Narrative Rail

Why This Compound

Chosen for endocrine and growth-hormone axis studies where protocol repeatability is critical.

Who This Is For

Research groups running GH-pulse, endocrine, and sleep-recovery model evaluations.

Proof Links

COA index Research-use terms

Select Size

17mg (11mg / 6mg) is currently out of stock. Use the stock alert below for restock notice.

Get notified as soon as this product is restocked.

Secure Checkout

Free Shipping $100+

100% Money Back

USA Made

Tesamorelin 11mg + Ipamorelin 6mg Blend is a combined research peptide format supplied as a 17mg lyophilized powder (11mg Tesamorelin + 6mg Ipamorelin). This pairing is commonly used in growth-hormone axis research when investigators want to study coordinated GHRH-pathway signaling (Tesamorelin) alongside GHSR-driven secretagogue activity (Ipamorelin).

In preclinical and assay settings, this blend is frequently used for GH/IGF-axis pathway mapping, pulsatility-focused experimental designs, and downstream biomarker work where researchers compare single-agent vs combined signaling effects across tissues.

Fast & Discrete Shipping

3rd Party Lab Tested (>99%)

Product Questions

Before You Order Tesamorelin + Ipamorelin Blend

Key ordering, documentation, and workflow answers for this product.

Tesamorelin + Ipamorelin Blend is sold strictly for lawful laboratory research use only. It is not intended for human or veterinary consumption, diagnosis, treatment, or consumer application.

Yes. Account login is required before checkout so payment, order history, compliance acknowledgements, and shipment updates remain attached to a verified customer profile.

Unavailable variants are disabled on the page. If the product is fully out of stock, you can submit your email for a restock notification.

Orders move into fulfillment after payment and verification steps are completed. Shipping expectations and carrier-related terms are documented in the published shipping policy.